Login to Your Account

As Expected, VaxGen's Second AidsVax Phase III In HIV Misses

By Kim Coghill

Thursday, November 13, 2003
VaxGen Inc.'s investigational vaccine for the prevention of HIV infection failed to hit primary or secondary endpoints in a Phase III trial conducted in Thailand. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription